We are live on ! Find out more
CSS

Cubist Systematic Strategies Portfolio holdings

AUM $21B
1-Year Est. Return 21.48%
This Fund
S&P 500
This Quarter Est. Return
+4.1%
1 Year Est. Return
+21.48%
3 Year Est. Return
+78.34%
5 Year Est. Return
+110.56%
10 Year Est. Return
+239.02%
AUM
$1.99B
AUM Growth
+$284M
Cap. Flow
+$258M
Cap. Flow %
12.95%
Top 10 Hldgs %
13.22%
Holding
2,248
New
441
Increased
650
Reduced
654
Closed
492

Sector Composition

Rank Sector Weight
1 Technology 15.96%
2 Consumer Discretionary 13.01%
3 Healthcare 12.59%
4 Industrials 12.57%
5 Financials 11.45%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
SIOX
1601
DELISTED
Sio Gene Therapies Inc. Common Stock
SIOX
$73K ﹤0.01%
4,049
-1,644
-29% -$24.2K
ADVM
1602
DELISTED
Adverum Biotechnologies
ADVM
$72K ﹤0.01%
1,353
-3,172
-70% -$191K
EVOP
1603
DELISTED
EVO Payments, Inc. Class A Common Stock
EVOP
$72K ﹤0.01%
+3,507
New +$73.5K
TGA
1604
DELISTED
Transglobe Energy Corp
TGA
$69K ﹤0.01%
+24,747
New +$49.5K
NTRI
1605
DELISTED
NutriSystem, Inc.
NTRI
$69K ﹤0.01%
1,789
-26,018
-94% -$863K
CLF icon
1606
Cleveland-Cliffs
CLF
$6.93B
$68K ﹤0.01%
8,032
-1,668
-17% -$13.3K
VHI icon
1607
Valhi
VHI
$390M
$67K ﹤0.01%
+1,166
New +$94K
AVDL
1608
DELISTED
Avadel Pharmaceuticals
AVDL
$66K ﹤0.01%
+10,820
New +$75.9K
FOLD
1609
DELISTED
Amicus Therapeutics
FOLD
$66K ﹤0.01%
+4,237
New +$64.1K
ABEV icon
1610
Ambev
ABEV
$47.3B
$65K ﹤0.01%
14,144
-13,056
-48% -$76.7K
IVZ icon
1611
Invesco
IVZ
$14B
$65K ﹤0.01%
+2,432
New +$70K
VTLE
1612
DELISTED
Vital Energy
VTLE
$65K ﹤0.01%
339
-3,020
-90% -$566K
MIK
1613
DELISTED
Michaels Stores, Inc
MIK
$65K ﹤0.01%
3,400
-99,950
-97% -$1.9M
GWR
1614
DELISTED
Genesee & Wyoming Inc.
GWR
$65K ﹤0.01%
800
-5,041
-86% -$382K
LUMO
1615
DELISTED
Lumos Pharma, Inc. Common Stock
LUMO
$64K ﹤0.01%
1,490
+54
+4% +$2.47K
ISEE
1616
DELISTED
IVERIC bio, Inc. Common Stock
ISEE
$64K ﹤0.01%
+23,500
New +$64.8K
OBSV
1617
DELISTED
ObsEva SA Ordinary Shares
OBSV
$64K ﹤0.01%
+4,238
New +$56.3K
SREV
1618
DELISTED
ServiceSource International, Inc.
SREV
$63K ﹤0.01%
15,873
-6,527
-29% -$25.9K
PZZA icon
1619
Papa John's
PZZA
$1.01B
$62K ﹤0.01%
1,217
-2,483
-67% -$139K
ROKU icon
1620
Roku
ROKU
$21.7B
$62K ﹤0.01%
1,465
+1,170
+397% +$42.7K
ATHX
1621
DELISTED
Athersys, Inc. Common Stock
ATHX
$62K ﹤0.01%
+1,268
New +$69.1K
HUD
1622
DELISTED
Hudson Ltd. Class A Common Shares
HUD
$62K ﹤0.01%
3,531
+1,725
+96% +$28.8K
SOS
1623
SOS Limited
SOS
$16.6M
$61K ﹤0.01%
4
HBM icon
1624
Hudbay
HBM
$11B
$59K ﹤0.01%
10,588
-69,831
-87% -$475K
FLY
1625
DELISTED
Fly Leasing Limited
FLY
$59K ﹤0.01%
4,217
-956
-18% -$13.2K

Similar funds

Cubist Systematic Strategies's Q2 2018 Portfolio in Review

As of Q2 2018, Cubist Systematic Strategies held 2,248 positions worth $1.99B, up 17% from $1.71B the previous quarter. Its ten largest holdings account for 13% of the portfolio.

Cubist Systematic Strategies deployed $258M of net new capital in Q2 2018, opening 441 new positions and adding to 650 existing holdings. Its largest new stake was Sage Therapeutics: 76,110 shares worth $11.9M.

By sector, the portfolio is most concentrated in Technology at 16% of assets, down from 18% a quarter earlier, followed by Consumer Discretionary and Healthcare.

On the sell side, the largest reduction was State Street SPDR S&P 500 ETF Trust, an estimated $59.2M trimmed.

  • Cubist Systematic Strategies's largest Q2 2018 buy was Sage Therapeutics: 76,110 shares worth $11.9M.
  • Cubist Systematic Strategies added most to ZENDESK INC in Q2 2018, an estimated $10.8M increase.
  • Cubist Systematic Strategies's biggest Q2 2018 reduction was State Street SPDR S&P 500 ETF Trust, cutting an estimated $59.2M.
  • Cubist Systematic Strategies fully exited TJX Companies in Q2 2018, selling an estimated $6.46M.
  • Cubist Systematic Strategies's ten largest holdings make up 13% of its $1.99B portfolio in Q2 2018.
  • Cubist Systematic Strategies opened 441 new positions and closed 492 in Q2 2018.
  • Cubist Systematic Strategies's portfolio value rose 17% quarter-over-quarter to $1.99B.

Based on Cubist Systematic Strategies's 13F filing for Q2 2018, filed 14 Aug 2018.